{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:25:03Z","timestamp":1783034703767,"version":"3.54.6"},"reference-count":56,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brightside Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: Substance use disorders (SUDs) remain a growing public health issue, with drug- and alcohol-related deaths continuing to increase. A myriad of barriers prevent many with SUDs from seeking care. Telehealth interventions are well-positioned to reduce barriers and increase engagement in SUD treatment. The SUD intensive outpatient program (IOP) is specifically designed for telehealth and offers evidenced-based care delivered by SUD professionals as well as asynchronous assignments to enhance treatment. This study explores the feasibility of providing a telehealth IOP. Methods: participant engagement, reasons for disengagement, and days of abstinence were examined using existing records from a cohort of participants between 2021 and 2023 (n = 4724). Results: Nearly 80% of participants remained engaged in the program for 30 days, and 91% attained at least 30 consecutive days of abstinence over the course of treatment. Nearly 45% demonstrated a successful response to care and no longer required IOP treatment. Those who finished the IOP completed over 70% of the asynchronous assignments. Conclusions: Results support the feasibility and effectiveness of delivering a telehealth IOP for SUDs.<\/jats:p>","DOI":"10.3390\/healthcare12242554","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T08:56:32Z","timestamp":1734512192000},"page":"2554","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient Engagement in Providing Telehealth SUD IOP Treatment: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"12","author":[{"given":"Joanna","family":"Contreras-Schwartz","sequence":"first","affiliation":[{"name":"Brightside Health, San Francisco, CA 94131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Brightside Health, San Francisco, CA 94131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Threlkeld","sequence":"additional","affiliation":[{"name":"Brightside Health, San Francisco, CA 94131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-9278","authenticated-orcid":false,"given":"Erin","family":"O\u2019Callaghan","sequence":"additional","affiliation":[{"name":"Brightside Health, San Francisco, CA 94131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirene","family":"Winsberg","sequence":"additional","affiliation":[{"name":"Brightside Health, San Francisco, CA 94131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"ref_1","unstructured":"Substance Abuse and Mental Health Services Administration (2024, September 09). National Survey on Drug Use and Health (NSDUH), Available online: https:\/\/www.samhsa.gov\/data\/release\/2022-national-survey-drug-use-and-health-nsduh-releases."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.15585\/mmwr.mm7308a1","article-title":"Deaths from Excessive Alcohol Use\u2014United States, 2016\u20132021","volume":"73","author":"Esser","year":"2024","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_3","unstructured":"Centers for Disease Control (2024, September 09). Provisional Drug Overdose Death Counts, Available online: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1515\/jom-2021-0163","article-title":"Review of medication-assisted treatment for opioid use disorder","volume":"122","author":"Ghanem","year":"2022","journal-title":"J. Osteopath. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.biopsych.2019.06.020","article-title":"Medication Treatment of Opioid Use Disorder","volume":"87","author":"Bell","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mayocpiqo.2021.01.013","article-title":"Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes","volume":"5","author":"Kirchoff","year":"2021","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/appi.prcp.20180006","article-title":"Pharmacological and Behavioral Treatment of Opioid Use Disorder","volume":"1","author":"Sofuoglu","year":"2019","journal-title":"Psychiatr. Res. Clin. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamainternmed.2017.3947","article-title":"Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial","volume":"177","author":"Watkins","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10826084.2023.2287192","article-title":"The Impact of Cognitive Behavioral Therapy for Substance Use Disorders on Veterans\u2019 Interpersonal Difficulties","volume":"59","author":"Norona","year":"2023","journal-title":"Subst. Use Misuse"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1037\/cps0000131","article-title":"An evaluation of cognitive behavioral therapy for substance use disorders: A systematic review and application of the society of clinical psychology criteria for empirically supported treatments","volume":"30","author":"Boness","year":"2023","journal-title":"Clin. Psychol. Sci. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"103648","DOI":"10.1016\/j.brat.2020.103648","article-title":"The search for mechanisms of cognitive behavioral therapy for alcohol or other drug use disorders: A systematic review","volume":"131","author":"Magill","year":"2020","journal-title":"Behav. Res. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107005","DOI":"10.1016\/j.addbeh.2021.107005","article-title":"Investigating interventions that lead to the highest treatment retention for emerging adults with substance use disorder: A systematic review","volume":"122","author":"Dalton","year":"2021","journal-title":"Addict. Behav."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e20557","DOI":"10.2196\/20557","article-title":"Understanding eHealth Cognitive Behavioral Therapy Targeting Substance Use: Realist Review","volume":"23","author":"Shams","year":"2021","journal-title":"J. Med. Internet Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/SAR.S362864","article-title":"Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appropriate?","volume":"14","author":"Magill","year":"2023","journal-title":"Subst. Abus. Rehabil."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e208279","DOI":"10.1001\/jamanetworkopen.2020.8279","article-title":"Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis","volume":"3","author":"Ray","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/NMD.0000000000001381","article-title":"The Effectiveness of Cognitive Behavioral Therapy Techniques for the Treatment of Substance Use Disorders: A Narrative Review of Evidence","volume":"209","author":"Zamboni","year":"2021","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13011-020-00293-3","article-title":"Mindfulness-based programs for substance use disorders: A systematic review of manualized treatments","volume":"15","author":"Korecki","year":"2020","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"key":"ref_18","first-page":"100467","article-title":"Mindfulness-based interventions in inpatient treatment for Substance Use Disorders: A systematic review","volume":"16","author":"Donate","year":"2022","journal-title":"Addict. Behav. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ramadas, E., Lima, M.P.D., Caetano, T., Lopes, J., and Dixe, M.D.A. (2021). Effectiveness of Mindfulness-Based Relapse Prevention in Individuals with Substance Use Disorders: A Systematic Review. Behav. Sci., 11.","DOI":"10.3390\/bs11100133"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s12671-020-01456-w","article-title":"Approach Coping and Substance Use Outcomes Following Mindfulness-Based Relapse Prevention Among Individuals with Negative Affect Symptomatology","volume":"11","author":"Roos","year":"2020","journal-title":"Mindfulness"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10673220490905723","article-title":"Group Therapy for Substance Use Disorders: What Do We Know?","volume":"12","author":"Weiss","year":"2004","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1357633X18775855","article-title":"Evidence for telehealth group-based treatment: A systematic review","volume":"25","author":"Gentry","year":"2019","journal-title":"J. Telemed. Telecare"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lo Coco, G., Graffeo, M.T., and Albano, G. (Group. Dyn. Theory Res. Pract., 2024). Implementing group therapy for adults with substance use disorders: What research-based evidence?, Group. Dyn. Theory Res. Pract., Advance online publication.","DOI":"10.1037\/gdn0000222"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.mayocp.2020.10.011","article-title":"Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook","volume":"95","author":"Oesterle","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jrh.12488","article-title":"Substance Use Disorder Treatment, Perceived Need for Treatment, and Barriers to Treatment Among Parenting Women With Substance Use Disorder in US Rural Counties","volume":"38","author":"Ali","year":"2022","journal-title":"J. Rural. Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11782218221118462","DOI":"10.1177\/11782218221118462","article-title":"Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews","volume":"16","author":"Farhoudian","year":"2022","journal-title":"Subst. Abus. Res. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jsat.2018.08.005","article-title":"Substance use consequences, mental health problems, and readiness to change among Veterans seeking substance use treatment","volume":"94","author":"Morris","year":"2018","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14659891.2019.1620891","article-title":"What motivates people with substance use disorders to pursue treatment? A patient-centered approach to understanding patient experiences and patient-provider interactions","volume":"24","author":"Gressler","year":"2019","journal-title":"J. Subst. Use"},{"key":"ref_29","unstructured":"U.S. Department of Health and Human Services (HHS) (2024, September 10). Office of the Surgeon General. Facing Addiction in America: The Surgeon General\u2019s Report on Alcohol, Drugs, and Health, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/28252892\/."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1178221818760551","DOI":"10.1177\/1178221818760551","article-title":"Predictors of Dropout From Inpatient Substance Use Treatment: A Prospective Cohort Study","volume":"12","author":"Andersson","year":"2018","journal-title":"Subst. Abus. Res. Treat."},{"key":"ref_31","unstructured":"Wilke, E., Markon, K.E., Freedland, T.A., and Predictors of Client Dropout from Intensive Outpatient Treatment for Substance Use Disorders (2024, September 12). Research Brief No. 9. Center for Practice Transformation, University of Minnesota., Available online: https:\/\/practicetransformation.umn.edu\/wp-content\/uploads\/2023\/01\/ResearchBrief_EarlyDropout_Final.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/ijmr.IJMR_1309_15","article-title":"Initial treatment dropout in patients with substance use disorders attending a tertiary care de-addiction centre in north India","volume":"146","author":"Basu","year":"2017","journal-title":"Indian J. Med. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e36263","DOI":"10.2196\/36263","article-title":"Telehealth Services for Substance Use Disorders During the COVID-19 Pandemic: Longitudinal Assessment of Intensive Outpatient Programming and Data Collection Practices","volume":"9","author":"Gliske","year":"2022","journal-title":"JMIR Ment. Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.2196\/34408","article-title":"In-Person Versus Telehealth Setting for the Delivery of Substance Use Disorder Treatment: Ecologically Valid Comparison Study","volume":"6","author":"Ngo","year":"2022","journal-title":"JMIR Form. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/ajad.13385","article-title":"Comparing substance use treatment initiation and retention between telehealth delivered during COVID-19 and in-person treatment pre-COVID-19","volume":"32","author":"Sistad","year":"2023","journal-title":"Am. J. Addict."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.15190\/d.2021.20","article-title":"Substance use during COVID-19 pandemic: Impact on the underserved communities","volume":"31","author":"Chacon","year":"2021","journal-title":"Discoveries"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/00952990.2021.1903023","article-title":"Common themes in early state policy responses to substance use disorder treatment during COVID-19","volume":"47","author":"Bouskill","year":"2021","journal-title":"Am. J. Drug Alcohol. Abus."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jrh.12570","article-title":"An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic","volume":"37","author":"Hughes","year":"2021","journal-title":"J. Rural. Health"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10826084.2023.2167496","article-title":"Effects of Telehealth on Dropout and Retention in Care among Treatment-Seeking Individuals with Substance Use Disorder: A Retrospective Cohort Study","volume":"58","author":"Gainer","year":"2023","journal-title":"Subst. Use Misuse"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1176\/appi.ajp.21111141","article-title":"Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder","volume":"179","author":"Lin","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/psychiatryint3020014","article-title":"Addiction and COVID: Issues, Challenges, and New Telehealth Approaches","volume":"3","author":"Edinoff","year":"2022","journal-title":"Psychiatry Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"100559","DOI":"10.1016\/j.hjdsi.2021.100559","article-title":"A novel transition: Lessons learned during rapid implementation and evolution of telehealth group based opioid treatment (t-GBOT) during the COVID-19 pandemic","volume":"9","author":"Sokol","year":"2021","journal-title":"Healthcare"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"29768357241255437","DOI":"10.1177\/29768357241255437","article-title":"Virtual Hybrid Versus In-Person Administration of Transcending Self Therapy for Veterans with Substance Use Disorders","volume":"18","author":"Bjork","year":"2024","journal-title":"Subst. Use Res. Treat."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"108359","DOI":"10.1016\/j.drugalcdep.2020.108359","article-title":"Expanding accessibility: Outpatient intensive treatment for substance use disorder during COVID-19 pandemic","volume":"218","author":"Faur","year":"2021","journal-title":"Drug Alcohol. Depend."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e2118487","DOI":"10.1001\/jamanetworkopen.2021.18487","article-title":"Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder","volume":"4","author":"Weintraub","year":"2021","journal-title":"JAMA Netw. Open."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/ADM.0000000000000871","article-title":"Virtual care in an outpatient subspecialty substance use disorder treatment program","volume":"16","author":"Levy","year":"2022","journal-title":"J. Addict. Medicine."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/10826084.2022.2079140","article-title":"Increased attendance during rapid implementation of telehealth for substance use disorders during COVID-19 at the largest public hospital system in the United States","volume":"57","author":"Avalone","year":"2022","journal-title":"Subst. Use Misuse"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e48701","DOI":"10.2196\/48701","article-title":"Association Between Clinician-Level Factors and Patient Outcomes in Virtual and In-Person Outpatient Treatment for Substance Use Disorders: Multilevel Analysis","volume":"10","author":"Welsh","year":"2023","journal-title":"JMIR Hum. Factors"},{"key":"ref_49","unstructured":"American Society of Addiction Medicine (2024, September 19). ASAM Criteria. Available online: https:\/\/www.asam.org\/asam-criteria."},{"key":"ref_50","unstructured":"Substance Abuse and Mental Health Services Administration (2024, September 19). Clinical Issues in Intensive Outpatient Treatment for Substance Use Disorders, Available online: https:\/\/store.samhsa.gov\/sites\/default\/files\/pep20-02-01-021.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1176\/appi.ps.201300249","article-title":"Substance abuse intensive outpatient programs: Assessing the evidence","volume":"65","author":"McCarty","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"108217","DOI":"10.1016\/j.jsat.2020.108217","article-title":"Effectiveness of value-based purchasing for substance use treatment engagement and retention","volume":"122","author":"Reif","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_53","first-page":"208933","article-title":"Predicting substance use disorder treatment follow-ups and relapse across the continuum of care at a single behavioral health center","volume":"147","author":"Waite","year":"2023","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1360-0443.2006.01310.x","article-title":"Rates and predictors of relapse after natural and treated remission from alcohol use disorders","volume":"101","author":"Moos","year":"2006","journal-title":"Addiction"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jsat.2010.01.007","article-title":"Predictors of motivation for abstinence at the end of outpatient substance abuse treatment","volume":"38","author":"Laudet","year":"2010","journal-title":"J. Subst. Abus. Treat."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/ajad.13571","article-title":"Predictors of abstinence maintenance after cocaine inpatient detoxification: A prospective study","volume":"33","author":"Poireau","year":"2024","journal-title":"Am. J. Addict."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/12\/24\/2554\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:54:42Z","timestamp":1760115282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/12\/24\/2554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":56,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["healthcare12242554"],"URL":"https:\/\/doi.org\/10.3390\/healthcare12242554","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]}}}